Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Ribavirin

EU orphan designation number: EU/3/01/029
Active ingredient: Ribavirin
Indication: Treatment of adenovirus infection in immunocompromised patients
Sponsor: Valeant Pharmaceuticals Limited
Cedarwood, Chineham Business Park, Crockford lane, Basingstoke RG24 8WD, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/03/2001 Centralised Orphan - Designation EMEA/OD/040/00 (2001)489 of 08/03/2001
28/06/2004 Other procedure
14/09/2007 Centralised Orphan - Removal of orphan designation from Community Register